Pain-relieving effect of analgesic-eluting urethral catheter placement after urologic surgery

Efficacy and safety of analgesic-eluting urethral catheter after transurethral surgery: Randomized Single-Blind Prospective Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0010974

Enrollment

Registered

2025-09-02

Start date

2024-05-07

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : [Common Procedure] Subjects: Patients requiring indwelling urinary catheter placement after transurethral resection of bladder tumor (TURBT) or transurethral resection of the prostate

however, the intervention group receives 0.5% lidocaine, while the control group receives normal saline. [Notes on Safety] The study drug (lidocaine) is designed for low-dose, continuous local infusi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Aged 19 years or older and under 75 years 2) Patients who have undergone transurethral resection of bladder tumor (TURBT) for the surgical treatment of bladder cancer with indwelling catheter placement, or transurethral resection of the prostate (TURP) for the surgical treatment of benign prostatic hyperplasia with indwelling catheter placement 3) Able to carry out normal daily activities (Eastern Cooperative Oncology Group performance status of 0 or 1) 4) Patients who can read and provide informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who have received or are scheduled to receive prior treatments for the condition, such as radiotherapy, chemotherapy, or hormone therapy, before or after surgery 2) Patients with a history of prior surgery or radiotherapy within the pelvic cavity 3) Patients requiring long-term indwelling urinary catheter (IUC) placement 4) Patients with an allergy to analgesics 5) Patients with severe hypertension 6) Patients who are pregnant 7) Patients who do not wish to participate in this study voluntarily 8) Patients deemed unsuitable for participation in the clinical trial by the investigator

Design outcomes

Primary

Measure	Time frame
Change in urethral pain score (VAS) from before catheter insertion to postoperative day 1	—

Secondary

Measure	Time frame
Change in quality of life (SF-12v2 score) before and after surgery;Degree of discomfort from catheter use	—

Countries

Korea, Republic of

Contacts

Public ContactU-Syn Ha

The Catholic University of Korea, Seoul St. Mary's Hospital

ushamd@catholic.ac.kr+82-2-2258-6224

Outcome results